Capstone Investment Advisors
CVAC

Capstone Investment Advisors’s CureVac CVAC Stock Holding History

Capstone Investment Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,700
Closed -$99.1K – 2159
2024
Q1 		$99.1K Buy
32,700
+2,700
+9% +$9.48K ﹤0.01% 2140
2023
Q4 		$126K Hold
30,000
– – ﹤0.01% 1904
2023
Q3 		$205K Buy
+30,000
New +$265K ﹤0.01% 1802

Other funds holding CVAC

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capstone Investment Advisors's CVAC Position: Q2 2024 in Review

Capstone Investment Advisors sold out of CureVac (CVAC) in Q2 2024, closing a stake of 32,700 shares — an estimated $99.1K sold.

Capstone Investment Advisors first reported a position in CVAC in Q3 2023 and held it in 3 quarters. The position peaked at $205K in Q3 2023. 87 funds tracked by Wall St. Rank hold CVAC as of Q2 2024.

  • Capstone Investment Advisors reported no remaining CureVac position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 32,700 CureVac shares in Q2 2024, an estimated $99.1K.
  • Capstone Investment Advisors first reported a position in CureVac in Q3 2023 and held it in 3 quarters.
  • Capstone Investment Advisors's CureVac position peaked at $205K in Q3 2023.
  • 87 funds tracked by Wall St. Rank held CureVac as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.